FDA Approves New Blood Test for Alzheimer's | Augusta Georgia News

FDA just approved Roche’s Elecsys Phospho-Tau blood test — the fourth Alzheimer’s diagnostic blood test in under two years. Designed for adults 55+, it helps doctors quickly assess cognitive decline and decide if deeper testing is needed, cutting down on lengthy exams and scans. The Alzheimer’s Association calls it a major win, praising the growing toolkit for early detection. This single biomarker test can both confirm and rule out key Alzheimer’s markers, potentially reshaping how doctors handle cognitive health — a huge leap forward for patients and families. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/d17dc8fef68c5ae7